Pharma Journalist 8778 posts 0 comments

AcelRx Pharmaceuticals announced the resubmission of the New Drug Application (NDA) for DSUVIA with the U.S. Food and Drug Administration (FDA). AcelRx anticipates that the FDA will…
Read More...

miRagen Therapeutics announced new interim data from its Phase 1 clinical trial of cobomarsen in patients with the mycosis fungoides (MF) form of cutaneous T-cell lymphoma (CTCL). The…
Read More...

SMi Reports: Two new speakers and sponsor have been announced to be joining the 8th annual BioBanking conference, taking place this June in London, UK There is just over a month…
Read More...

XtalPi Inc. announced a strategic research collaboration with Pfizer Inc. to develop a hybrid physics- and artificial intelligence (AI)-powered software platform for accurate molecular…
Read More...

Takeda Pharmaceutical Company Limited and Shire plc announced that they have reached agreement on the terms of a recommended offer pursuant to which Takeda will acquire the entire…
Read More...

In patients who have suffered from a heart attack, a large portion of heart cells die, which may cause heart failure and significant mortality and morbidity. The aim of the…
Read More...

Wave Life Sciences Ltd. announced that Pfizer recently nominated the fourth and fifth final hepatic targets under the collaboration agreement between the two companies to develop…
Read More...

Provention Bio, Inc. (Provention) announced that it has selected Netherlands-based Intravacc to lead product development and manufacturing of clinical trial material for Provention's…
Read More...

SMi introduces their inaugural conference on Cell & Gene Therapy which takes place between the 10th and 11th of October 2018, with 2 interactive pre-conference workshops on the 9th…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX (daratumumab) in combination with VELCADE …
Read More...